European markets close mixed; Novo Nordisk shares jump 9%, extending rally after GLP-1 pill approval
The Stoxx 600 notched a new record closing high on Tuesday, buoyed by Copenhagen-listed Novo Nordisk.
TL;DR
- European markets closed mixed on Christmas Eve.
- Novo Nordisk's share price increased significantly after gaining FDA approval for a GLP-1 pill.
- Sanofi announced the acquisition of U.S. company Dynavax for $2.2 billion.
- Sportswear brand Puma's share price fell, with the company having recently secured bridge loans and credit.
- Gold and silver futures hit fresh highs this week.
- Several individuals, including former EU commissioner Thierry Breton, received U.S. visa bans for alleged censorship of U.S. social media platforms.
- Asia-Pacific markets traded mostly higher, and U.S. stock futures were near the flatline.